Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Girls-Boys: An Investigation of Gender Differences in the Behavioral and Neural Mechanisms of Trust and Reciprocity in Adolescence.

Lemmers-Jansen ILJ, Fett AJ, Shergill SS, van Kesteren MTR, Krabbendam L.

Front Hum Neurosci. 2019 Aug 2;13:257. doi: 10.3389/fnhum.2019.00257. eCollection 2019.

2.

The role of expecting feedback during decision-making under risk.

Rigoli F, Martinelli C, Shergill SS.

Neuroimage. 2019 Aug 8;202:116079. doi: 10.1016/j.neuroimage.2019.116079. [Epub ahead of print]

PMID:
31400531
3.

Kaleidoscope.

Tracy DK, Joyce DW, Albertson DN, Shergill SS.

Br J Psychiatry. 2019 Sep;215(3):571-572. doi: 10.1192/bjp.2019.189. No abstract available.

PMID:
31397249
4.

Clozapine and cardiotoxicity - A guide for psychiatrists written by cardiologists.

Patel RK, Moore AM, Piper S, Sweeney M, Whiskey E, Cole G, Shergill SS, Plymen CM.

Psychiatry Res. 2019 Jul 24:112491. doi: 10.1016/j.psychres.2019.112491. [Epub ahead of print] Review.

PMID:
31351758
5.

Kaleidoscope.

Tracy DK, Joyce DW, Albertson DN, Shergill SS.

Br J Psychiatry. 2019 Aug;215(2):511-512. doi: 10.1192/bjp.2019.176. No abstract available.

PMID:
31288891
6.

Examining belief and confidence in schizophrenia - ADDENDUM.

Joyce DW, Averbeck BB, Frith CD, Shergill SS.

Psychol Med. 2019 Jul 8:1. doi: 10.1017/S0033291719001363. [Epub ahead of print] No abstract available.

PMID:
31280731
7.

Corrigendum to "Aging effects on functional auditory and visual processing using fMRI with variable sensory loading" [Cortex 49 (2013) 1304-1313].

Cliff M, Joyce DW, Lamar M, Dannhauser T, Tracy DK, Shergill SS.

Cortex. 2019 Jun 20. pii: S0010-9452(19)30227-8. doi: 10.1016/j.cortex.2019.06.001. [Epub ahead of print] No abstract available.

PMID:
31253413
8.

Corrigendum to "Dysconnectivity of neurocognitive networks at rest in very-preterm born adults" [NeuroImage: Clinical 4 (2014) 352-365].

White T, Symington I, Castellanos NP, Brittain PJ, Walsh SF, Nam KW, Sato JR, Allin MPG, Shergill SS, Murray RM, Williams SCR, Nosarti C.

Neuroimage Clin. 2019 Jun 20:101901. doi: 10.1016/j.nicl.2019.101901. [Epub ahead of print] No abstract available.

9.

Correction to: A systematic review of the effects of low-frequency repetitive transcranial magnetic stimulation on cognition.

Lage C, Wiles K, Shergill SS, Tracy DK.

J Neural Transm (Vienna). 2019 Jun 21. doi: 10.1007/s00702-019-02027-7. [Epub ahead of print]

PMID:
31222607
10.

Kaleidoscope.

Tracy DK, Joyce DW, Albertson DN, Shergill SS.

Br J Psychiatry. 2019 Jul;215(1):441-442. doi: 10.1192/bjp.2019.136. No abstract available.

PMID:
31196249
11.

Correction: Reduced Crowding and Poor Contour Detection in Schizophrenia Are Consistent with Weak Surround Inhibition.

Robol V, Tibber MS, Anderson EJ, Bobin T, Carlin P, Shergill SS, Dakin SC.

PLoS One. 2019 Jun 13;14(6):e0218483. doi: 10.1371/journal.pone.0218483. eCollection 2019.

12.

Correction: Amphetamine Sensitization Alters Reward Processing in the Human Striatum and Amygdala.

O'Daly OG, Joyce D, Tracy DK, Azim A, Stephan KE, Murray RM, Shergill SS.

PLoS One. 2019 Jun 12;14(6):e0218478. doi: 10.1371/journal.pone.0218478. eCollection 2019.

13.

Correction: Local and Global Limits on Visual Processing in Schizophrenia.

Tibber MS, Anderson EJ, Bobin T, Carlin P, Shergill SS, Dakin SC.

PLoS One. 2019 Jun 12;14(6):e0218466. doi: 10.1371/journal.pone.0218466. eCollection 2019.

14.

Prevalence of serum N-methyl-d-aspartate receptor autoantibodies in refractory psychosis - ADDENDUM.

Beck K, Lally J, Shergill SS, Bloomfield MAP, MacCabe JH, Gaughran F, Howes OD.

Br J Psychiatry. 2019 Aug;215(2):507. doi: 10.1192/bjp.2019.141. Epub 2019 Jun 10. No abstract available.

PMID:
31180301
15.

Unheard voices: outcomes of tertiary care for treatment-refractory psychosis - ADDENDUM.

Sarkar SN, Tracy DK, Fernandez MM, Nalesnik N, Dhillon G, Onwumere J, Prins AM, Schepman K, Collier T, White TP, Patel A, Gaughran F, Shergill SS.

BJPsych Bull. 2019 Aug;43(4):194. doi: 10.1192/bjb.2019.40. Epub 2019 Jun 10. No abstract available.

16.

Corrigendum to "Modulation of somatosensory processing by action" [Elsevier, 70 (2013) 356-362].

Shergill SS, White TP, Joyce DW, Bays PM, Wolpert DM, Frith CD.

Neuroimage. 2019 Aug 15;197:827. doi: 10.1016/j.neuroimage.2019.05.057. Epub 2019 May 29. No abstract available.

17.

Correction to: Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia.

Tracy DK, Joyce DW, Sarkar SN, Fernandez MM, Shergill SS.

BMC Psychiatry. 2019 May 27;19(1):160. doi: 10.1186/s12888-019-2155-y.

18.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2019 Jun;214(6):379-380. doi: 10.1192/bjp.2019.111. No abstract available.

PMID:
31088593
19.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2019 May;214(5):312-313. doi: 10.1192/bjp.2019.86. No abstract available.

PMID:
31012415
20.

Cognitive correlates of abnormal myelination in psychosis.

Vanes LD, Mouchlianitis E, Barry E, Patel K, Wong K, Shergill SS.

Sci Rep. 2019 Mar 26;9(1):5162. doi: 10.1038/s41598-019-41679-z.

21.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2019 Apr;214(4):242-243. doi: 10.1192/bjp.2019.50. No abstract available.

PMID:
30896381
22.

Mapping cortical surface features in treatment resistant schizophrenia with in vivo structural MRI.

Barry EF, Vanes LD, Andrews DS, Patel K, Horne CM, Mouchlianitis E, Hellyer PJ, Shergill SS.

Psychiatry Res. 2019 Apr;274:335-344. doi: 10.1016/j.psychres.2019.02.028. Epub 2019 Feb 14.

PMID:
30851596
23.

Integrated care in mental health: next steps after the NHS Long Term Plan.

Tracy DK, Hanson K, Brown T, James AJB, Paulsen H, Mulliez Z, Shergill SS.

Br J Psychiatry. 2019 Jun;214(6):315-317. doi: 10.1192/bjp.2019.46. Epub 2019 Mar 5.

PMID:
30832746
24.

Kaleidoscope.

Tracy DK, Joyce DW, Shergill SS.

Br J Psychiatry. 2019 Mar;214(3):178-179. doi: 10.1192/bjp.2019.28. No abstract available.

PMID:
30774063
25.

Dopamine manipulations drive changes in information sampling in healthy volunteers.

Vicario-Feliciano R, Wigton RL, White TP, Shergill SS, Averbeck BB.

J Psychopharmacol. 2019 Jun;33(6):670-677. doi: 10.1177/0269881118822080. Epub 2019 Jan 15.

PMID:
30644326
26.

An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients.

Gilleen J, Farah Y, Davison C, Kerins S, Valdearenas L, Uz T, Lahu G, Tsai M, Ogrinc F, Reichenberg A, Williams SC, Mehta MA, Shergill SS.

Psychopharmacology (Berl). 2018 Dec 8. doi: 10.1007/s00213-018-5134-y. [Epub ahead of print]

PMID:
30536081
27.

Cooperation and sensitivity to social feedback during group interactions in schizophrenia.

Hanssen E, Fett AK, White TP, Caddy C, Reimers S, Shergill SS.

Schizophr Res. 2018 Dec;202:361-368. doi: 10.1016/j.schres.2018.06.065. Epub 2018 Jul 10.

PMID:
30005931
28.

Long-term follow-up of clozapine prescribing.

Gee SH, Shergill SS, Taylor DM.

J Psychopharmacol. 2018 May;32(5):552-558. doi: 10.1177/0269881118760666. Epub 2018 Apr 25.

PMID:
29692222
29.

Integration is not necessarily at odds with reductionism.

Joyce DW, Shergill SS.

Int J Soc Psychiatry. 2018 Nov;64(7):626-627. doi: 10.1177/0020764018770476. Epub 2018 Apr 11. No abstract available.

PMID:
29638180
30.

Differential neural reward mechanisms in treatment-responsive and treatment-resistant schizophrenia.

Vanes LD, Mouchlianitis E, Collier T, Averbeck BB, Shergill SS.

Psychol Med. 2018 Oct;48(14):2418-2427. doi: 10.1017/S0033291718000041. Epub 2018 Feb 14.

PMID:
29439750
31.

Real-time fMRI neurofeedback to down-regulate superior temporal gyrus activity in patients with schizophrenia and auditory hallucinations: a proof-of-concept study.

Orlov ND, Giampietro V, O'Daly O, Lam SL, Barker GJ, Rubia K, McGuire P, Shergill SS, Allen P.

Transl Psychiatry. 2018 Feb 12;8(1):46. doi: 10.1038/s41398-017-0067-5.

32.

White matter changes in treatment refractory schizophrenia: Does cognitive control and myelination matter?

Vanes LD, Mouchlianitis E, Wood TC, Shergill SS.

Neuroimage Clin. 2018 Jan 28;18:186-191. doi: 10.1016/j.nicl.2018.01.010. eCollection 2018.

33.

When the drugs don't work: treatment-resistant schizophrenia, serotonin and serendipity.

Lowe P, Krivoy A, Porffy L, Henriksdottir E, Eromona W, Shergill SS.

Ther Adv Psychopharmacol. 2018 Jan;8(1):63-70. doi: 10.1177/2045125317737003. Epub 2017 Nov 2.

34.

Hope is a therapeutic tool.

Bressan RA, Iacoponi E, Candido de Assis J, Shergill SS.

BMJ. 2017 Dec 13;359:j5469. doi: 10.1136/bmj.j5469. No abstract available.

PMID:
29237595
35.

Decreased value-sensitivity in schizophrenia.

Martinelli C, Rigoli F, Dolan RJ, Shergill SS.

Psychiatry Res. 2018 Jan;259:295-301. doi: 10.1016/j.psychres.2017.10.031. Epub 2017 Oct 23.

PMID:
29096335
36.

Stimulating thought: a functional MRI study of transcranial direct current stimulation in schizophrenia.

Orlov ND, O'Daly O, Tracy DK, Daniju Y, Hodsoll J, Valdearenas L, Rothwell J, Shergill SS.

Brain. 2017 Sep 1;140(9):2490-2497. doi: 10.1093/brain/awx170.

PMID:
29050384
37.

Hearts and Minds: Real-Life Cardiotoxicity With Clozapine in Psychosis.

Joy G, Whiskey E, Bolstridge M, Porras-Segovia A, McDonagh TA, Plymen CM, Shergill SS.

J Clin Psychopharmacol. 2017 Dec;37(6):708-712. doi: 10.1097/JCP.0000000000000792.

PMID:
29049078
38.

Patient attitudes to clozapine initiation.

Gee SH, Shergill SS, Taylor DM.

Int Clin Psychopharmacol. 2017 Nov;32(6):337-342. doi: 10.1097/YIC.0000000000000188. Erratum in: Int Clin Psychopharmacol. 2019 Sep;34(5):273.

PMID:
28704228
39.

Are we failing clinical trials? A case for strong aggregate outcomes.

Joyce DW, Tracy DK, Shergill SS.

Psychol Med. 2018 Jan;48(2):177-186. doi: 10.1017/S0033291717001726. Epub 2017 Jun 29.

PMID:
28659228
40.

Rapid-onset clozapine-induced loss of glycaemic control: case report.

Porras-Segovia A, Krivoy A, Horowitz M, Thomas G, Bolstridge M, Ion D, Shergill SS.

BJPsych Open. 2017 May 11;3(3):138-140. doi: 10.1192/bjpo.bp.117.004481. eCollection 2017 May.

41.

The value of novelty in schizophrenia.

Martinelli C, Rigoli F, Averbeck B, Shergill SS.

Schizophr Res. 2018 Feb;192:287-293. doi: 10.1016/j.schres.2017.05.007. Epub 2017 May 9.

42.

White matter deficits in schizophrenia are global and don't progress with age.

Kanaan RA, Picchioni MM, McDonald C, Shergill SS, McGuire PK.

Aust N Z J Psychiatry. 2017 Oct;51(10):1020-1031. doi: 10.1177/0004867417700729. Epub 2017 Apr 6.

43.

Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit.

Gee SH, Taylor DM, Shergill SS, Flanagan R, MacCabe JH.

Ther Adv Psychopharmacol. 2017 Feb;7(2):79-83. doi: 10.1177/2045125316677027. Epub 2016 Dec 2.

44.

An fMRI-compatible force measurement system for the evaluation of the neural correlates of step initiation.

de Lima-Pardini AC, de Azevedo Neto RM, Coelho DB, Boffino CC, Shergill SS, de Oliveira Souza C, Brant R, Barbosa ER, Cardoso EF, Teixeira LA, Cohen RG, Horak FB, Amaro E Jr.

Sci Rep. 2017 Feb 23;7:43088. doi: 10.1038/srep43088.

45.

Realising stratified psychiatry using multidimensional signatures and trajectories.

Joyce DW, Kehagia AA, Tracy DK, Proctor J, Shergill SS.

J Transl Med. 2017 Jan 18;15(1):15. doi: 10.1186/s12967-016-1116-1.

46.

Stimulating cognition in schizophrenia: A controlled pilot study of the effects of prefrontal transcranial direct current stimulation upon memory and learning.

Orlov ND, Tracy DK, Joyce D, Patel S, Rodzinka-Pasko J, Dolan H, Hodsoll J, Collier T, Rothwell J, Shergill SS.

Brain Stimul. 2017 May - Jun;10(3):560-566. doi: 10.1016/j.brs.2016.12.013. Epub 2016 Dec 28.

PMID:
28057452
47.

Visual Population Receptive Fields in People with Schizophrenia Have Reduced Inhibitory Surrounds.

Anderson EJ, Tibber MS, Schwarzkopf DS, Shergill SS, Fernandez-Egea E, Rees G, Dakin SC.

J Neurosci. 2017 Feb 8;37(6):1546-1556. doi: 10.1523/JNEUROSCI.3620-15.2016. Epub 2016 Dec 26. Erratum in: J Neurosci. 2018 Mar 28;38(13):3373-3374.

48.

Inflammatory response to clozapine in the absence of myocarditis: case report.

Davey P, Gee S, Shergill SS.

BJPsych Open. 2016 Jun 22;2(3):244-246. eCollection 2016 May.

49.

Self-harm and suicidal acts: a suitable case for treatment of impulsivity-driven behaviour with repetitive transcranial magnetic stimulation (rTMS).

Tracy DK, Shergill SS, David AS, Fonagy P, Zaman R, Downar J, Eliott E, Bhui K.

BJPsych Open. 2015 Sep 2;1(1):87-91. eCollection 2015 Jun. Review.

50.

Reduced susceptibility to the sound-induced flash fusion illusion in schizophrenia.

Vanes LD, White TP, Wigton RL, Joyce D, Collier T, Shergill SS.

Psychiatry Res. 2016 Nov 30;245:58-65. doi: 10.1016/j.psychres.2016.08.016. Epub 2016 Aug 6.

PMID:
27526318

Supplemental Content

Loading ...
Support Center